• WisBusiness

Monday, August 12, 2013

Tom Still: Baldwin’s visit illustrates value of R&D to human health, economy


By Tom Still
Tammy Baldwin readily admits she has a soft spot for academic researchers and the federal dollars that often help to support them. Her grandfather was a UW-Madison biochemist who worked at the Institute for Enzyme Research for decades.

So it's no surprise that Wisconsin's first-term U.S. senator would spend time thinking about how her work on Senate committees dealing with health, education, energy and homeland security might intersect with academic researchers – and the ideas they often bring to the marketplace.

That was the theme of Baldwin's visit to the UW-Madison campus and University Research Park during a broader state swing tied to the Senate's August break. It provided a revealing glimpse at some of the challenges facing academic research, and its valuable byproducts, in an era of federal spending cuts.

A meeting with the scientific and business team of Isomark at the Wisconsin Institutes for Discovery was a case study of how basic research can blossom into technologies that can be used to diagnose and treat human health problems, if only the support is there long enough to get the idea to market maturity.

Isomark is commercializing a UW-licensed technology that detects critical infections, such as sepsis and ventilator-associated pneumonia, which can be acquired in hospital intensive-care units. Because Medicare no longer reimburses for hospital-acquired infections and other costs are rising, hospitals themselves need an early warning system to head off trouble before it gets out of hand. Isomark's technology focuses on changes in carbon isotopes in exhaled carbon dioxide, which can be tracked non-invasively using only a sample of the patient's breath.

Test results so far are extremely encouraging, but the hard part for the company is only beginning.

Having raised money through federal merit-based grants, private investors and the Wisconsin Alumni Research Foundation to get this far, Isomark now faces a long regulatory approval process. The Food and Drug Administration must be persuaded the device is safe and effective, and other federal regulators will determine if it saves enough money to become eligible for a federal reimbursement program.

"We have a great team and a great product," said Joe Kremer, Isomark's chief executive officer, so meeting that burden of regulatory proof is not insurmountable. "But the money needed to get there is a hurdle to be overcome."

That's where Baldwin enters the picture. Her first bill, introduced in July, is the Small Business Innovation Act of 2013. It would authorize the federal Small Business Administration to set up a fund to match with private dollars invested in young biotechnology, advanced manufacturing and clean energy companies. The fund would give preference to startups that have already received grants from the National Science Foundation, the National Institutes of Health or the 31-year-old Small Business Innovation Research Foundation.

It remains to be seen if the bill moves ahead in Washington's polarized political environment, where even more basic funding for scientific research is at risk. Automatic federal budget cuts mean most merit-based grant programs will be reduced – federal earmarks are already a thing of the past – and that could mean big trouble over time for major research universities such as the UW-Madison.

Baldwin told the campus gathering she's also worried about what that funding crunch will mean for the next generation of researchers, especially if they think they're entering a dead-end profession. "The career path for a young scientist is challenging," she said.

There are legitimate policy disagreements over how far the federal government should go in supporting academic research and development, or the companies that stem from such R&D. But federal investment in such research has been a reality for a century or more – and it has produced enormous results for human health and the economy. Curbing federal deficits is one thing; turning back the R&D clock by decades is quite another.

By the way, had Baldwin lost her 2012 race against Tommy Thompson, the former Republican governor and U.S. Health and Human Services secretary, the philosophical approach in this Senate seat would not have been all that different. Thompson has been an ardent supporter of smart R&D investments, as well. As for Wisconsin's second senator, Republican Ron Johnson, it may be time for him to end his radio silence on the issue.

-- Still is president of the Wisconsin Technology Council. He is the former associate editor of the Wisconsin State Journal in Madison.

Labels:


Comments: 1

At October 24, 2013 at 3:05 AM, OpenID jonesosmosis said...

If you need to do a research that can directly challenge the commonly known educational standards as well as propose new ideas you can use our writing service. We help students who have to cover lots of inforation due to their young age lack practical experience in writing free examples of research proposals at Goodexamplepapers.com on the given topic at their university or other establishment. My own study will surely become a theoretical part of some study in future.

 

Post a Comment

Back to BizOpinion main page

: See newer blog items : : See older blog items :

BizOpinion site feed
ADVERTISEMENT
ADVERTISEMENT

wisbusiness.com Social News

Follow Us

Site Sponsors

ARCHIVE

· January 2009
· February 2009
· March 2009
· April 2009
· May 2009
· June 2009
· July 2009
· August 2009
· September 2009
· October 2009
· November 2009
· December 2009
· January 2010
· February 2010
· March 2010
· April 2010
· May 2010
· June 2010
· July 2010
· August 2010
· September 2010
· October 2010
· November 2010
· December 2010
· January 2011
· February 2011
· March 2011
· April 2011
· May 2011
· June 2011
· July 2011
· August 2011
· September 2011
· October 2011
· November 2011
· December 2011
· January 2012
· February 2012
· March 2012
· April 2012
· May 2012
· June 2012
· July 2012
· August 2012
· September 2012
· October 2012
· November 2012
· December 2012
· January 2013
· February 2013
· March 2013
· April 2013
· May 2013
· June 2013
· July 2013
· August 2013
· September 2013
· October 2013
· November 2013
· December 2013
· January 2014
· February 2014
· March 2014
· April 2014
· May 2014
· June 2014
· July 2014
· August 2014
· September 2014
· October 2014
· November 2014
· December 2014
· January 2015
· February 2015
· March 2015
· April 2015
· May 2015
· June 2015
· July 2015
· August 2015
· September 2015
· October 2015
· November 2015
· December 2015
· January 2016
· February 2016
· March 2016
· April 2016
· May 2016
· July 2016
· August 2016
· October 2016
· December 2016
Copyright ©2013 WisBusiness.com All rights reserved. | WisOpinion.com | WisPolitics.com  |  Website development by wisnet.com LLC  | Website design by Makin’ Hey Communications